WILMINGTON, Del. due to violations of the Federal Law on False Claims և the Law on Controlled Substances. Prior to the sale of its bankrupt assets, CCSP provided a range of mental health and addiction treatment services across multiple locations in Delaware.
The CCSP has agreed to a $ 13,757,520.60 ավել judgment increase in interest to resolve claims that the CCSP has violated the False Claims Act by making payments for mental health services to individuals whose professional qualifications did not allow charge them Medicare or Medicaid compensation և Medicaid payment for mental health services using the wrong procedure code for the service provider, which will result in higher than allowed payments. The CCSP also agreed to a $ 1,621,571 judgment ավել interest rate increase to address claims that it violated the Federal Surveillance Act by negligently maintaining proper records of the use of controlled substances, including methadone buprenorphine. Treatment of patients with substance use disorders և Transfer of controlled substances to sites առանց without proper documentation.
On April 19, 2021, shortly after the United States filed these two lawsuits, the CCSP filed for bankruptcy. On June 15, 2021, CCSP completed the sale of its assets և operations under the jurisdiction of the Bankruptcy Court to Conexio Care, Inc. և Coras Wellness and Behavioral Health, which now provides mental health ում supplementary services previously provided by CCSP. . CCSP և United States Settlement Agreements և Agreements have yet to be approved by a bankruptcy court, ցանկացած The final amount of any U.S. reparations will be limited to bankruptcy funds to be paid to the United States. և Other CCSP creditors.
“For many years, Connections improperly charged government mental health service programs, failed to properly monitor, and document its stockpiles of controlled substances,” said Attorney General Weiss. “These settlements, together with the transfer of all connection services to action providers, are finally resolving Connections’ long history of poor legal compliance, which has jeopardized the state’s potential mental health and drug abuse treatment. Delaware. “
“These allegations portray CCSP as a health care provider that has really disrupted patients’s their federal health care plans,” said Maureen Dixon, Special Agent for the Office of the Inspector General of Health and Human Services (HHS-OIG). “Medicare և Medicaid’s fake account shows that there is no stability for the beneficiaries of these programs depending on their services. HHS-OIG continues to work with our law enforcement partners to combat such fraud. ”
“Drug treatment programs such as Connections have been entrusted with the provision of drugs such as methadone buprenorphine to help people with substance use disorders. However, with that responsibility comes the obligation to properly document the use and transfer of these same drugs, ”said Thomas Hodnett, Acting Special Officer in the Field Department of Philadelphia. “This civil judgment serves as a notice of compliance with the law on controlled substances to ensure compliance with the storage requirements for drugs used for adjuvant drug treatment.”
The regulation of the Law on False Claims announced today partially resolves the lawsuit providing information on the Law on False Claims. The government’s claims are based on information provided by two former CCSP staff members. Ist newcomer suit, or qui tam: The False Claims Act is initiated by an individual known as a “relative” by filing a sealed grievance with the U.S. District Court, providing a copy of the grievance and providing other evidence to the U.S. Attorney General. The United States then has the opportunity to investigate those claims. The False Claims Act gives the whistleblower a share of the government’s recovery. Separate from the settlement announced to date, the: qui tam: The relationship continues to file additional claims against CCSP’s former CEO Catherine Dane McKay.
The United States continues to prosecute McCay, as well as two other corporate executives, William Norte and Stephen DeGis, for violating the law on controlled substances, which is not part of the settlement announced today.
Assistants to the US Attorney Jes Jesse S. Wenger և Laura D. Assistants to U.S. Attorneys Dylan Ste and Steinberg և Laura D.
Related court documents և Information from the civil suit is in PACER, looking for case number 1. 19-cv-475-CFC for False Claims Act և 1. 21-cv-00514-MN for the Act of Controlled Materials.